| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Odškodninska odgovornost za nepričakovane neželene učinke zdravil: primerjava slovenske in nemške ureditve : magistrsko delo
Authors:ID Brndušić, Nina (Author)
ID Samec Berghaus, Nataša (Mentor) More about this mentor... New window
Files:.pdf MAG_Brndusic_Nina_2025.pdf (2,56 MB)
MD5: E0480868AFA11DC60FC84B268CA4C3F5
 
Language:Slovenian
Work type:Master's thesis/paper
Typology:2.09 - Master's Thesis
Organization:PF - Faculty of Law
Abstract:Zdravila že od nekdaj spremljajo človeštvo kot nepogrešljiv del zdravljenja in ohranjanja zdravja. Namenjena so izboljšanju kakovosti življenja, vendar je njihova uporaba pogosto zaznamovana z napetostjo med koristmi in tveganji, saj lahko povzročijo nasprotno od pričakovane koristi, tj. neželene učinke. Zaradi tveganj se pojavlja potreba po učinkoviti ureditvi odškodninske odgovornosti, katere glavni cilj je zaščita uporabnikov zdravil, hkrati pa se ne sme zavirati razvoja in dostopnosti zdravil. Posebne pravne izzive povzročajo nepričakovani neželeni učinki, ki niso vnaprej znani uporabnikom in lahko v nekaterih primerih povzročijo resno škodo. V nalogi je obravnavana pravna ureditev odškodninske odgovornosti za neželene učinke zdravil, pri čemer se primerjalno analizirata slovensko in nemško pravo. Ugotovljeno je, da sta obe ureditvi zasnovani na objektivni odgovornosti, vendar med njima obstajajo pomembne razlike, tako na ravni materialnega kot tudi procesnega prava. V slovenskem pravu je področje sicer zakonsko urejeno, vendar ostaja pomanjkljivo razvito v praksi, kar oškodovancem otežuje položaj. Nemška ureditev je na drugi strani normativno bolj izdelana in dopolnjena z obsežno sodno prakso, ki oblikuje jasnejše standarde za presojo odgovornosti. Vprašanja, ki so obravnavana v nalogi so ključna, saj ne glede na strogo regulacijo, zaradi same narave zdravil in njihove široke uporabe prihaja do nastanka škode, čemur se je nemogoče popolnoma izogniti. Pregledna in jasna obravnava možnosti doseganja odškodnine, ki jo ima uporabnik pa je zanj zelo pomembna. Bistveno je tudi katera pravila za povrnitev škode se uporabijo v primerih nepričakovanih neželenih učinkov. Del naloge je osredotočen na nemško ureditev, ki je na področju zdravil zelo natančna in ureja mnoga vprašanja, ki v Sloveniji ostajajo neurejena. Posebej je izpostavljeno vprašanje vzročne zveze, ki v slovenski posebni (lex specialis) ureditvi za področje zdravil ni izrecno urejena, zato se rešuje s pomočjo splošnih pravil o objektivni odgovornosti. Nasprotno pa nemška pravna ureditev vključuje natančnejša pravila, ki v določenih primerih omogočajo domnevo vzročne zveze.
Keywords:farmakovigilanca, odškodninska odgovornost, klinično preskušanje, producentska odgovornost, varstvo potrošnikov
Place of publishing:Maribor
Place of performance:Maribor
Publisher:N. Brndušić
Year of publishing:2025
Number of pages:1 spletni vir (1 datoteka PDF (V, 71 str.))
PID:20.500.12556/DKUM-95073 New window
UDC:347.4/.5:61(043.3)
COBISS.SI-ID:251468547 New window
Publication date in DKUM:02.10.2025
Views:304
Downloads:78
Metadata:XML DC-XML DC-RDF
Categories:PF
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:03.09.2025

Secondary language

Language:English
Title:Tortious liability for unexpected adverse drug reactions: a comparison of slovenian and german regulations
Abstract:Medicines have accompanied humanity since the earliest times as an indispensable part of treatment and the preservation of health. They are intended to improve quality of life, but their use is often marked by a tension between benefits and risks, as they can cause the opposite of the expected benefit, i.e. adverse reactions. Due to these risks, there arises a need for an effective regulation of liability for damages, the primary aim of which is the protection of medicine users, while at the same time not hindering the development and accessibility of medicine. Particular legal challenges are posed by unexpected adverse reactions, which are not known in advance to users and can, in some cases, cause serious harm. The master’s thesis addresses the legal regulation of liability for adverse drug reactions, with a comparative analysis of Slovenian and German law. It is concluded that both systems are based on strict liability, yet there are significant differences between them, both at the level of substantive and procedural law. In Slovenian law, the field is regulated by statute, but it remains underdeveloped in practice, which puts injured parties in a disadvantaged position. German regulation, on the other hand, is more normatively refined and complemented by extensive case law, which establishes clearer standards for assessing liability. The issues addressed in the master’s thesis are crucial, as damage occurs despite strict regulation, due to the very nature of medicines and their widespread use, which makes harm unavoidable. A transparent and clear discussion of the possibilities for obtaining compensation is therefore of great importance to the user. It is also essential to know which rules for compensation apply in cases of unexpected adverse reactions. Part of the thesis focuses on the German regulation, which is highly detailed in the pharmaceutical field and addresses many issues that remain unregulated in Slovenia. Particular attention is placed on the concept of causation, which in the Slovenian special (lex specialis) regulation for the pharmaceutical sector is not explicitly defined, and is therefore addressed through the general rules of strict liability. In contrast, the German legal framework includes more precise rules which allow for a presumption of causation in certain cases.
Keywords:pharmacovigilance, tortious liability, clinical trials, product liability, consumer protection


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica